- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/106 - VibrioCampylobacter
Détention brevets de la classe A61K 39/106
Brevets de cette classe: 119
Historique des publications depuis 10 ans
|
3
|
3
|
8
|
4
|
1
|
1
|
4
|
1
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Intervet International B.V. | 1301 |
7 |
| The United States of America as represented by the Secretary of the Navy | 2807 |
6 |
| The Governors of the University of Alberta | 876 |
5 |
| The Brigham and Women's Hospital, Inc. | 2232 |
4 |
| MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. | 23 |
4 |
| Elanco Tiergesundheit AG | 416 |
4 |
| The Regents of the University of California | 20315 |
3 |
| Jiangnan University | 1569 |
3 |
| Lee, Shee Eun | 5 |
3 |
| Rhee, Joon Haeng | 5 |
3 |
| Sumitomo Chemical Company, Limited | 9106 |
2 |
| Idemitsu Kosan Co., Ltd. | 4226 |
2 |
| The Kitasato Institute | 159 |
2 |
| Ostrich Pharma KK | 16 |
2 |
| UEA Enterprises Limited | 66 |
2 |
| University of Guelph | 360 |
2 |
| University of Louisville Research Foundation, Inc. | 723 |
2 |
| Valneva Sweden AB | 9 |
2 |
| Quadram Institute Bioscience | 43 |
2 |
| Novartis AG | 10511 |
1 |
| Autres propriétaires | 58 |